The outlook change reflects Moody’s Investors Service’s uncertainty about the outcome of CHS’ strategic review.
Moody’s also affirmed CHS’ existing ratings, including its “B2” corporate family rating and “B2-PD” probability of default rating.
The actions follow CHS’ announcement that it is exploring a variety of options with financial sponsors.
More articles on healthcare finance:
West Virginia has saved more than $1M by enrolling inmates in Medicaid
AdvantEdge Healthcare Solutions achieves recertification for HIPAA and HITECH conformity
Spotlight Innovation reveals debt restructuring plan
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
